Pallas Capital Advisors LLC United Therapeutics Corp Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 1,792 shares of UTHR stock, worth $623,096. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,792
Previous 1,895
5.44%
Holding current value
$623,096
Previous $679,000
6.92%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
692Shares Held
60.6MCall Options Held
194KPut Options Held
298K-
Wealthfront Advisers LLC18.3MShares$6.37 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.53 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$994 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...